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 Background: Acute Dextran Sodium Sulfate (DSS)-induced colitis is an 
inflammatory ailment limited to the colon. It works to destroy the morphology and gut 
barrier goblet and epithelial cells that aid in providing homeostasis. Selenium (Se) is an 
essential micronutrient that has anti-inflammatory and antioxidant properties and is 
known to play a role in reducing inflammation in areas elsewhere in the body. The 
current study is focused on how Se alters gut barrier permeability and functionality 
related to the recovery of tight junction regulation and mucin secretion. Methods: 
C57BL/6 mice were randomly placed into control (normal water) and 2% DSS water 
receiving groups and within these groups they were randomly given either a Se rich diet 
or a control diet ad libidum. Hemotoxylin-Eosin and Alcian Blue staining was used to 
study the colon morphology and to quantify the goblet to epithelial cell ratio. Western 
Blot was used to analyze protein expression levels for MUC-2 and ZO-1. Gut barrier 
permeability was assessed by administering FD4 and determining its plasma 
concentration by spectrofluorescence. ELISA was used to study the colon-secreted 
cytokine levels of TNF-α and IL-1β. Results: DSS + Se mice showed significantly lower 
clinical scores, histopathology, and higher goblet to epithelial cell ratios compared to 
DSS mice given a control diet. It is interesting to note that there was a main effect of diet 
and DSS treatment with ZO-1 expression.  We found no significant difference between 
the groups for gut permeability as well as for MUC-2 expression, and IL-1β or TNF-α 
v 
secretion. Conclusion: The data suggests that Se works to reduce the severity of colitis by 
increasing ZO-1 expression and goblet cell content. 
Keywords: Selenium; Acute Colitis; Inflammation; Gut Barrier; Mucin; Tight Junction 
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CHAPTER 1: PROPOSAL 
INTRODUCTION 
Inflammatory bowel disease (IBD) has been a growing concern in the United 
States and all over the world. IBD can be classified as either Ulcerative Colitis (UC) or 
Crohn’s Disease (CD) and has been characterized by chronic uncontrolled inflammation 
that results in damage to the lining of the gastrointestinal tract, blood in stools, diarrhea, 
and weight loss (Abraham, 2009; Matter, 2011). It is estimated that as many as 1.4 
million American’s, or 1 in every 200 people, suffer from IBD and as many as 70,000 
new cases appear each year (Hanauer, 2006). The peak onset of the disease has been 
shown to be from 15 to 30 years of age with most recent data suggesting a higher 
incidence before the age of 20 (Abraham, 2009; M’Koma 2013). Studies have shown that 
individuals suffering from IBD for at least 6-8 years are six times more likely to develop 
colorectal cancer (M’Koma 2013; Mattar, 2011).  Acute colitis is a single inflammatory 
flare-up that presents the same symptoms of IBD except on a much lower scale 
(Keshavarzian, 2003). These acute flare-ups have been attributed to genetic and non-
genetic factors. However, genetics have only been able to account for 20-25% of 
susceptibility, while environmental (diet, exercise, drugs, smoking, and social stress), 
immunological, and microbial factors play a larger role (Keshavarzian, 2003). Acute 
colonic flare-ups that are frequent and reoccurring are more indicative of chronic 
inflammation, which may lead to the development of IBD.
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The GI tract must prevent leakage of gut bacteria into the abdominal cavity for if 
it does not, acute inflammatory immune responses may occur (Matricon, 2008; 
McGuckin, 2009). The intestines are home to trillions of commensal bacteria that make 
up a microbiome. This population of bacteria is tightly regulated and the immune system 
is highly responsive in distinguishing harmful bacteria from commensal (Johannson, 
2013). Studies examining IBD development have found concomitant intestinal barrier 
dysfunction and increased intestinal permeability allowing bacteria to leak outside of the 
intestines (Matricon, 2010). The gut barrier is made of an outer mucus layer and an inner 
single layer of epithelial cells that are held together by tight junctions (TJ) (Antoni, 
2014). TJ are composed of zona occludens (ZO) that are located at the apical surface of 
the epithelial cells. These cell junctions are the rate-limiting step in paracellular 
permeability (Clayburgh, 2004). Inflammation can downregulate their overall expression 
and translocate them to the inside of the cell away from the surface causing increased 
paracellular leakage of noxious bacteria (Ma, 2004). Inflammatory cytokines tumor 
necrosis factor alpha (TNF-α) and interleukin factor 1 beta (IL-1β have been shown to be 
able to alter intestinal TJ permeability (Ma, 2004; Wang, 2005). Furthermore, reactive 
oxygen species (ROS) may also cause oxidative stress-induced inflammation and lead to 
decreased intestinal barrier function by downregulation of TJ proteins (Keshavarzian, 
2003). TJs are the main regulatory site for paracellular permeability and are highly 
investigated in inflammatory diseases (Clayburgh, 2004). However, further research is 
needed in examining nutritional effects on TJ expression as well as how these effects may 




In addition to tight junction regulation, the secretive functions of gut epithelial 
cells can have a role in intestinal permeability. The mucus layer is composed of a two-
layered system that regulates the luminal bacterial environment and is important for the 
protection of the barrier epithelial cells (Johansson, 2013). The inner layer is formed by 
mucins (Muc 2, 3, and 4) that are secreted by goblet cells. In this layer there is relatively 
no bacteria, which provides the protective function to the epithelial cells. On the other 
hand, the outer layer has the same mucins as the inner layer, but here is where the 
bacteria in the gut thrive (Johansson, 2013). UC cases show diminished outer layer of 
mucus causing the bacteria and other noxious agents to move to the inside layer putting 
them in direct contact with apical epithelial surface. The diminished outer layer has been 
correlated with a loss of goblet cells and their secreted mucins (Dorofeyev, 2013). While 
mucous production is important for gut protection, further work is needed to determine 
how nutrition impacts the secretory function of gut epithelial cells. 
Selenium (Se) is an essential micronutrient that exerts its anti-inflammatory and 
antioxidant effects through many families of selenoproteins. Dietary supplementation of 
Se has been shown to play a role in thyroid hormone metabolism, cardiovascular health, 
prevention and reduction of cancer, and immune function (Huang, 2012).  A deficiency in 
Se has been negatively correlated with IBD, which suggests a crucial role of Se in 
inflammatory pathology (Barrett, 2013). Research has shown that Se can shift 
macrophage polarization from an M1 pro-inflammatory state to an M2 anti-inflammatory 
state after an insult of injury (Nelson, 2011). Additionally, glutathione peroxidases (Gpx), 
a major family of selenoproteins, have been found to decrease inflammation, reduce 
ROS, and decrease cancer incidence in mouse models of inflammation-associated 
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carcinogenesis (Krehl, 2012). Deficiency in subtypes of Gpx, Gpx-1, Gpx-2, or both, 
have shown development of spontaneous intestinal inflammation and increased apoptosis 
of intestinal epithelial cells (Edelblum, 2006; Krehl, 2012).  While Se has shown 
beneficial effects in various disease states the effects on gut barrier dysfunction, 
especially tight junction regulation and mucus production, is not very well understood.  
Se has demonstrated positive effects in reducing inflammation and preserving 
epithelial cells. In cell models of human breast cancer, Se has enhanced the function of 
TJs by relocation of ZO-1 proteins to the apical surface, thus decreasing permeability 
(Martin, 2007).  Additionally, rat models examining stress and chemically induced gastric 
ulcers have found Se to prevent gastric wall mucus depletion. (al-Moutairy, 1996).  The 
current study is focused on how Se alters gut barrier functionality related to the recovery 
of tight junction regulation and mucin secretion.  However, there are currently gaps in our 
understanding or how Se can impact intestinal barrier function in a mouse model of acute 
colitis. Thus, we examined Se function with a widely used mouse model of intestinal 
inflammation, dextran sodium sulfate (DSS) - induced colitis (Perse, 2012). This model 
has demonstrated acute, chronic, and relapsing experimental inflammation and has been 
shown to closely resemble human IBD (Okayasu, 1990; Perse, 2012).  
PURPOSE AND AIMS 
The purpose of this study is to examine the preventive and restorative effect of Se 
on acute DSS-induced colitis in C57BL/6 mice. The severity of colitis in the mice will be 
observed through assessment of clinical score and histopathology. Inflammatory 
mediators that will be studied include expression of inflammatory cytokines TNF-α and 
IL-1β and localization of pro-inflammatory transcription factor Nf-κβ.  Variables of gut 
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barrier function that will be studied include ZO-1 expression and localization, gut 
permeability, mucus protein content, and goblet cell content. The overall hypothesis is 
that a Se rich diet will decrease the severity of colitis by decreasing inflammation, 
decreasing gut permeability, and increasing mucus protein content. 
Specific Aim #1 will determine the effect of Se rich diet on the severity of colitis in mice 
with DSS-induced colitis. The primary outcomes measured will be clinical score and 
histopathology to indicate severity of colitis. The score consists of weight loss, diarrhea, 
and hemoccult. We hypothesize that a Se rich diet will decrease the severity of colitis by 
decreasing clinical score and histopathology as compared to control diet.  
Specific Aim #2 will determine the effect of Se rich diet on gut barrier function in mice 
with DSS-induced colitis. Primary outcomes measured will be gut barrier permeability. 
Secondary outcomes include mucus protein expression, goblet cell content, tight junction 
expression, and secreted tissue expression of inflammatory cytokines. We hypothesize 
that a Se rich diet will improve gut barrier function by decreasing gut permeability as 
compared to control diet. We also hypothesize that these positive changes will be 
associated with increased mucus protein expression, goblet cell content, and tight 




Figure 1.1 Working Model: This study is aimed to uncover the proposed model of the 
protective effect of Se on gut barrier function in C57BL/6 mice with acute DSS-
induced colitis. The overall hypothesis is that a Se rich diet will decrease the severity 
of colitis by decreasing inflammation, decreasing gut permeability, and increasing 



























Animals and Housing 
Four to five week old male and female C57BL/6 mice  (n=33) were bred and 
maintained in the animal resource facility at the University of South Carolina. They were 
housed three-five per cage and maintained on a 12:12 light-dark cycle in a low stress 
environment (22°, 50% humidity, low noise). Mice were split into two main groups: 
control and experimental. The control group consisted of a mixed population, while only 
males were placed in the experimental groups. Each main group was subdivided into 
mice receiving either a Control diet (0.02ppm Se) or a Se rich diet (0.75ppm Se). After 1 
week of either diet, experimental mice were given 2% Dextran Sodium Sulfate (DSS) 
(MP Biochemicals, MW 36,000 – 50,000) dissolved in their drinking water for 5 days 
followed by 5 days of normal drinking water to induce acute colitis. Control mice were 
given normal drinking water ad libitum throughout the duration of the study. All animal 
experiments were approved by the University of South Carolina’s Institutional Animal 
Care and Use Committee.  
Monitoring Animal Health 
Food and water intake, as well as body weight, were measured every alternate day 
for all mice throughout the length of the study. During and following DSS treatment in 
experimental groups, mice were observed every alternate day for clinical signs of disease, 
which included weight loss, diarrhea, and positive fecal hemoccult. Weight loss was
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ranked by a point system as follows: 0= 0-5% weight loss; 1=6-10% weight loss; 2=11-
15% weight loss; 3=16-20% weight loss; and 4=>20% weight loss. The appearance of 
diarrhea was ranked as 0= well-formed pellets, 2= pasty and semi-formed stools that do 
not adhere to the anus, 4= liquid stools with no form that do not adhere to the anus. 
Positive hemoccult was scored as follows: 0= no blood or negative hemoccult, 2= some 
blood (<50%) or positive hemoccult, and 4= gross bleeding (>50%) using hemoccult kit 
(Beckman Coulter). The clinical score was then determined by adding and totaling the 
scores of weight loss, diarrhea, and hemoccult. 
Tissue Collection 
 All mice were sacrificed 17 days after initial induction of Se rich or Control diet. 
The mice were sacrificed within 2 hours by cervical dislocation and tissue collection was 
performed as a non-survival surgery. The mouse colon was excised and flushed with PBS 
(EMD Chemicals) and three 1cm sections of each were cut. The first section was stored 
at -80°C for protein expression studies. The second section was fixed in formalin (Fisher 
Scientific) and stored in 70% ethanol, which was later cut into 5-6μm thin sections for 
use in Hemotoxylin and Eosin (H&E) and Alcian Blue and Nuclear Fast Red staining. 
The last section was placed in 12-well plates containing 1ml of RPMI 1640 media that 
included 1% Penicillin-streptomycin (Mediatech, Inc) per well and was incubated for 24 
hours at 37°C and 5% CO2. The RPMI media containing tissue cytokines was 
centrifuged at 10,000g for 10 minutes at 15°C and the supernatant was collected and 






 The histopathology of the colon was observed through H&E staining. A standard 
protocol for H&E staining was used. The severity of colitis was quantified by a scale of 0 
to 4, where 0= no infiltration and inflammation; 2= moderate infiltration and 
inflammation; and 4= severe infiltration and inflammation with distorted crypts. Alcian 
Blue and Neutral Fast Red staining was used to detect goblet and epithelial cells in the 
colon. Goblet cells were stained blue with Alcian Blue and epithelial cells were stained 
pink with Neutral Fast Red. They were quantified by goblet to epithelial ratio using 6 
crypts per colon section from each mouse for all treatment groups.  
Gut Permeability 
Gut barrier integrity was assessed in all mice by permeability to FITC-dextran 
(MWav= 4000; FD4) (Sigma Aldrich). The FD4 was administered by gavage based on 
the animal’s body weight in grams and diluted with 125mg/ml of PBS to five hour fasted 
mice. Plasma was sampled before and 1 h after FD4 administration and measured for 
florescence as previously described by Yang et al., 2003.  
Enzyme-linked Immunosorbant Assay 
The RPMI medium supplemented with secreted colon cytokines was used to 
quantify the local concentrations of TNFα and IL-1β (BD biosciences) using 
commercially available BD OptEIA enzyme-linked immunoabsorbant assay (ELISA) 
kits, according to the manufacturer’s instructions. The local cytokine concentrations were 






Colon tissue samples frozen at -80°C were homogenized in RIPA buffer that was 
supplemented with protease and phosphatase inhibitors (SIGMA). The samples were then 
centrifuged at 10,000 rpm for 15 minutes and the supernatant was collected for protein 
analysis by a standard Bradford assay. Protein homogenate from all groups was 
electrophoresed on 7% SDS-PAGE gels and transferred to a nitrocellulose membrane for 
3 hours at 4°C. The membrane was blocked by 1X PBS and 0.1% Tween 20 for 1 hour 
and subsequently probed for ZO-1 (Abcam) and MUC-2 (Abcam) overnight. The bands 
were detected using chemiluminescence and normalized relative to GAPDH expression 
(Genetex). The bands were quantified by densitometry and expressed as mean area 
density by using Image J software (Image J).  
Statistical Analysis 
XLStat for Windows (verson 2009.4.07) statistical software was used to perform all 
statistical analysis. Independent two-tailed t-tests were used to determine significance for 
all single variables. Statistical significance was considered at P < 0.05 level of confidence 
REVIEW OF LITERATURE 
The literature review for this study is divided into three main sections with further 
subcategories to explore knowledge more in depth on specific topics. The first section 
divulges inflammation and its role within injury and the immune response. The second 
section draws attention to the gut barrier, its components, and how it relates to 
inflammatory events. The final section sheds knowledge on the dietary nutrient called 
selenium. This section will explore in detail the functions and roles of selenium in the 
body and how it may be used as a therapeutic treatment. Furthermore, the current 
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knowledge of links between gut barrier dysfunction, inflammation, and selenium will be 
reviewed in this section.   
I. Inflammation  
Injury or infection of tissues sets off chemical and physical signals that allow 
infiltration of blood cells and fluid in order to promote healing. These events are 
called an inflammatory response, which is a type of defense mechanism housed 
within the immune system of the body. Its primary purpose is to contain, neutralize, 
dilute, or wall off deleterious agents and has been characterized by distinct cardinal 
signs, such as heat, swelling, redness, pain, and sometimes loss of function 
(Anderson, 2001; Medzhitov, 2008).  Inflammation may seem to be more 
degenerative than reparative, but if closely regulated it plays a pivotal role in the 
wound healing process. An acute response has been characterized by immediate and 
nonspecific events. The immediate inflammatory action calls for the activation of 
local macrophages and mast cells that release inflammatory mediators, such as 
chemokines and cytokines, in order to attract white blood cells and clotting agents to 
divest infectious agents for wound repair (Medzhitov, 2008). The white blood cells, 
mainly neutrophils, and plasma proteins are normally housed within the 
cardiovascular system and may venture into local tissue if the endothelial membrane 
becomes leaky or slightly more permeable than normal. This infiltration of 
inflammatory agents is necessary for repairing tissue damage, but it must be tightly 
regulated and resolved quickly in order to decrease the risk for increasing mortality 
and morbidity for diseases such as rheumatoid arthritis, diabetes, Crohn’s disease, 
and atherosclerosis (Tracey, 2002). A chronic response has been characterized by 
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delayed and highly specific events, which is more of an unregulated inflammatory 
response with an abundance of inflammatory mediators and white blood cells as 
compared to acute inflammation (Eming, 2007; Ryan, 1977). Moreover, chronic 
inflammation has been widely studied as a mechanism of the development of 
modern human diseases, such as cancer (Shacter, 2002), Inflammatory Bowel 
Disease (Zhang, 2012), Alzheimers (Bibi, 2014), and Chronic Obstructive 
Pulmonary Disease (Maclay, 2013). 
A. The Pathway of Inflammation 
Injury promotes the immediate activation of an immune mediated response 
that allows infiltration of polymorphonuclear (PMN) leukocytes, mainly 
neutrophils, through the endothelial membrane. This process occurs via the 
activation of the membrane by local proinflammatory cytokines: Tumor 
Necrosis Factor-α (TNF-α), Interleukin -1β (IL-1β), and Interferon-γ (IFN-γ) 
(Eming, 2007). After several days, the neutrophils are joined by larger 
populations of activated macrophages via attraction by monocyte 
chemoattractant protein -1 (MCP-1). Macrophages are widely studied 
phagocytes that are thought to have primarily deleterious effects on tissues. 
However, not only do they encompass a proinflammatory phenotype (M1), 
but they also present an antagonist side, the anti-inflammatory phenotype 
(M2). Studies have shown that M1 is the predominant phenotype during the 
initial phase of acute inflammation due to its high T helper cell-1 (Th-1) 
cytokine response (Mantovani, 2013; Romagnani, 2000). The Th-1 response is 
activated by TNF-α, which binds to toll-like receptors and TNF-α receptors 
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located on the plasma membrane of macrophages. The binding stimulates a 
cascade affect that activates protein kinase C (a major regulatory 
Phosphorylation protein). PKC may phosphorylate Iκβ, which is bound to 
nuclear factor kappa beta (Nfκβ) (Aveleira, 2010). Phosphorylation of this 
complex allows Nf-κβ to dislocate into the nucleus, which promotes the 
transcription of proinflammatory mediators, such as TNF-α, IL-1β, IL-6, 
reactive oxygen species (ROS), inducible Nitric Oxide Synthase (iNOS) 
CXCL9 and CXCL10 (Chazaud, 2014; Dohi, 2014; Lawrence, 2009; 
Mantovani, 2013). After the wound has been cleansed of debris, further 
leakage of cell contents has ceased, and neutrophils are phagocytized, the 
macrophage will undergo polarization to an M2 phenotype to initiate the 
second phase – healing (Ramaiah, 2007). The M2 response is of Th-2 type 
and is activated by transforming growth factor-β (TGF-β), IL-1, IL-4, and IL-
10 and its primary role is to promote tissue repair and regeneration in order to 
recover functionality of the damaged tissue (Chazaud, 2014). These activating 
factors bind to the cell surface receptors on the macrophage and illicit 
transcription and release of anti-inflammatory mediators (IL-4, IL-13, IL-10, 
arginase, proline, CCL17, CCL22, and CCL24, VEGF, and MMPs), which 







II. Inflammation and the Gut 
A. Epithelial Barrier 
The gastrointestinal tract involves a large tube-like structure that runs from the 
mouth to the anus. Consumed nutrients travel on the luminal side and remain 
there unless excreted or selectively absorbed by the single layer of epithelial 
cells that line this tract. The intestines are the primary areas in the 
gastrointestinal tract that allow absorption of nutrients that are vital for 
homeostatic functionality. Moreover, selective permeability is one of the key 
protective functions of the intestinal epithelial cells. This feature allows the 
uptake of nutrients and minimal exposure to various toxins, antigens, and 
microorganisms (Lennernas, 1998). Molecules and ions may be selectively 
taken into the epithelial cells through two types of transport. The first is 
transcellular – the intake of substances through the apical membrane on the 
extracellular surface or the basolateral membrane on the luminal side. 
However, substances taking this route of transport require either a lipophilic 
composition or a specific mechanism of ATP-dependent transport across the 
membrane. Substances that do not have access to either of these requirements 
may take the second route of transport – paracellular. This is the route, by 
which the substances may travel into the intercellular space between adjacent 
epithelial cells. However, this pathway is tightly regulated by cell junctions 





1. Cell Junctions 
i. Tight junctions – A type of epithelial and endothelial cell junction 
located on the apical surface of the membrane. Tight junctions play a 
vital role in paracellular transport by tightly regulating permeability of 
essential molecules and ions and keeping out noxious agents (Gu, 
2011). The degree of permeability may fluctuate due to the local 
mucosal or luminal environmental stimuli as well as various 
physiological and pathological conditions. Tight junctions are 
integrated via an array of proteins as well as with an association of 
scaffolding proteins. Occludins are transmembrane proteins that have a 
PDZ domain that directly regulates paracellular trafficking or 
permeability (Hwang, 2013).  Zona Occludins (ZO) are cytoplasmic 
scaffolding proteins that hold occludins in proper orientation through 
interaction with the PDZ domain and binding to actin located in the 
cell cytoskeleton. These PDZ domains allow scaffolding and structural 
interaction of ZO and occludins by spacing these proteins in close 
proximity (Gonzalez-Mariscal, 2000). The final proteins of interest 
that play a pivotal role in permeability are the claudin family. These 
proteins vary in their degree of leakiness and this function allows 
permeability of certain types of ions (i.e claudin-8 reduces Na2+ 
permeability) (Gonzalez-Mariscal, 2008). 
ii. Other Cell Junctions – Tight junctions may be the most apical junction 
and highly important in permeability; however, there are other 
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junctions to consider in regard to cell-cell environmental homeostasis. 
The adherens junctions are located directly below the tight junctions. 
The main structural protein components in these junctions consist of 
cadherins (Dejana, 1995). They come in a variety of types, the most 
important being E-cadherin. It comprises specific roles of cell-cell 
adhesion and interaction with the actin cytoskeleton components. In 
order for E-cadherin to exhibit these roles, it must be joined in a 
complex with catenins (alpha, beta, or gamma)(Dejana, 1995). Gap 
junctions reside below adherens junctions and are involved in cell-cell 
exchange of ions and low molecular weight molecules. The passage of 
molecules and ions is conducted through hemichannels made of 
proteins called connexins. In the gastrointestinal tract, they are found 
in abundance in the inner smooth muscle and studies have shown that 
they may influence the contractile activity of the gut (Nielsen, 2012). 
B. Mucus Layer 
The GI lining in the mouth and the esophagus have multiple layers of 
squamous epithelial cells. However, the stomach, small intestine, and large 
intestine have a single, thin layer of these cells causing increased vulnerability 
to damage and pathology. Aiding in protective defenses to these epithelial 
cells in the lower part of the GI tract is the mucus layer. Mucus is a 
transparent liquid layer that covers epithelial cells lining the GI tract and it is 
made of proteins known as mucins. There are two different types of mucins: 
classic gel forming (MUC2, MUC5AC, MUC5B, and MUC6) and 
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transmembrane (MUC1, MUC3, MUC4, MUC12, MUC13, MUC16, and 
MUC17) (Johansson, 2011). The small intestine has a single mucus layer, 
while the large intestine is composed of 2 distinct layers with separate 
functionality. The single layer of mucus in the small intestine is composed of 
the mucus protein MUC2, as well as antibacterial peptides, which allows this 
layer to be unattached to the epithelial cells and easily removable (Johansson, 
2011). The function of the mucus in this region is to keep the surface of the 
epithelia as well as within the crypts where stem cells lie as sterile as possible. 
The colon is doubly lined with an outer mucus layer that is composed of 
MUC2 that resembles the single mucus layer of the small intestine, while the 
inner mucus layer is composed of MUC2 that is bound to the surface of the 
epithelia by attachment of goblet cells (Johansson, 2013).  The MUC2 from 
the inner layer gradually becomes the outer layer in order to renew damaged 
mucin proteins from noxious agents. The functionality of the two layers 
remains separate. The inner layer protects the single layer of epithelial cells 
from consumed deleterious agents and is considered a sterile environment, 
while the outer layer houses the large populations of bacteria that make up the 
microbiome of the large intestine. The bacteria found here is ultimately 
essential for normal functionality of the colon and as long as it is regulated 
and within the outer layer of mucus, the colon may function without 
developed pathologies (Johansson, 2013). Like the epithelial cells, the mucus 
layer is constantly renewed in order to keep up proper functionality. The notch 
signaling pathway promotes differentiation of stem cells into absorptive cells 
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(epithelial cells) via hairy and enhancer of split-1 (HES-1) and when this 
pathway is inhibited the secretory linage of cells or goblet cells are 
differentiated by MATH-1 (Jeon, 2013). 
C. Barrier Dysfunction via Inflammation 
Inflammation is not only a process, by which healing occurs, but it has also 
been studied as a mechanism for the development of disease. Studies have 
shown that low grade inflammation involving infiltration of activated T cells 
that release TNF-α and other noxious agents may be a primary contributing 
factor in disease development, especially in the colon (Piche, 2014). Not only 
does TNF-α stimulate the activation of Nfκβ to promote further inflammation, 
but it also stimulates the disassembly of tight junction proteins (Aveleira, 
2010). Studies have elucidated that PKC is an important regulator of tight 
junction permeability. Activation of PKC may target downstream proteins, 
such as Nfκβ or it may circle back and target the tight junctions themselves 
(Aveleira, 2010; Gonzalez-Mariscal, 2008). PKC is not the only protein that 
regulates tight junctions; myosin light chains (MLC) may alter their 
permeability as well. TNF-α and IL-1 stimulate the phosphorylation of 
MLCs by activating myosin light chain kinases (MLCK). This promotes the 
rearrangement of actin filaments in the cytoskeleton and loss of structural 
support for the tight junctions, thus allowing increased permeability (Turner, 
2009; Wang, 2005). Beta-Catenin (-Catenin) is a cytoplasmic protein that 
allows adherens junctions to be connected to the actin cytoskeleton for 
structural support, thus maintaining their ability to keep cells in close 
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proximity and aiding in tight regulation of permeability (Hurst, 1999). 
Stimulation of the MLCK causes a contraction of the actin filaments in the 
cytoskeleton, which results in rearrangement of not only ZO-1, but also -
catenin (Hurst, 1999). These rearrangements lead to increased permeability 
and allow infiltration of immune cells into the lumen of the GI tract and 
subsequent inflammation. The goblet cell proteins HES-1 and MATH-1 are 
important in UC and CD disease development (Zheng, 2011). Studies have 
found that the expression of the transcription factor Hath-1 is essential for 
goblet cell differentiation and that HES-1 suppresses Hath-1 leading to 
suppression of goblet cell formation, which results in decreased mucus layers. 
In UC there is an abnormal expression of HES-1, which promotes further 
suppression of goblet cells (Zheng, 2011). 
III. Selenium, Inflammation, and the Gut 
A. Selenium 
Selenium (Se) is an essential trace element apart of the semimetals that is 
incorporated into proteins – selenoproteins – via co-translational modification 
by selenocysteine (SeCys). It is found within many food sources such as egg 
noodles (34.7ug), beef liver (57.0ug), brazil nuts (839.2ug), canned tuna 
(80.4ug), plain yogurt (8.1ug), and mushrooms (4.3ug) as well as a variety of 
others (Holben, 1999).  Intake of Se is an average of 40ug per day in Europe 
and between 93ug (women) and 134ug (men) in the USA (Rayman, 2012). 
Selenoproteins are a growing area of research and have so far been found to 
reduce cancer, cancer-related mortality, and virulence associated with viral 
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infections, regulate thyroid hormones and function, improve mental health and 
reproductive performance, and act as a potent antioxidant. Recently, multiple 
studies have elucidated the role of Se on reducing the mortality of a variety of 
cancers as well as possible metastasis (Clark, 1996; Harris, 2012; Nagy, 2013; 
Rayman, 2012; Wrobel, 2013).  The mechanism of action has been found to 
be through sufficient activation of c-Jun NH2-terminal kinase 1 (JNK1) 
leading to decreased -catenin signaling with subsequent decreased cell 
proliferation (Fang, 2010). 
Dietary or supplemental Se-species are absorbed in the GI tract and are routed 
to the liver where it is sorted into either the pathway for excretion by the 
kidneys or for synthesis into other Se metabolites. Regulation of these 
distribution pathways as been postulated as both active and passive; however, 
it has not been elucidated as to which has primary control. Most Se is 
transported out of the liver to other various locations as selenoprotein P (SeP), 
where it may be metabolized into other families of selenoproteins. The main 
family of importance is the glutathione peroxidases (GPxs) whose primary 
properties include antioxidant functions. There are four GPx members: Gpx1 
(cytosolic) – functions to reduce retroviral virulence, GPx2 (gastrointestinal) – 
shows anti-apoptotic functions in colon crypts and maintains intestinal 
mucosal integrity, GPx3 (plasma) – antioxidant within extracellular fluids, 
and finally GPx4 (phospholipid) – present in high concentrations in the testis 




B. Selenium and inflammation 
The immune system relies on many defense mechanisms, such as generation 
of reactive oxygen species (ROS) and inflammatory responses to protect the 
body from pathogens and noxious agents. During an immune reaction ROS 
may rise above normal concentrations, which may damage cell membranes, 
proteins, or DNA causing mutations and possibly dysfunction (Huang, 2012). 
H2O2 is a species of ROS that acts as a signaling molecule in the activation of 
cysteine residues. GPxs target the H2O2 species and metabolizes them into 
non-harmful agents. Preventative studies in humans have shown TNF-α 
stimulated immune cells having markedly higher expression of GPxs and are 
dependent on ROS concentration (Defi, 2011; Huang, 2012). Additionally, Se 
may downregulate cytokine and adhesion molecule expression that are 
released by macrophages (Roman, 2014). Studies looking at Se deficiency 
and/or GPx Knockout (KO) mice show higher incidence for cancer as well as 
spontaneous development of intestinal inflammation (Krehl, 2012; Roman, 
2014). Inflammatory responses may not be a single event, but may be termed 
as a flare-up and occur frequently or more gradually over a period of time. 
During these flare-ups the actively inflamed mucosa shows reduced GPx 
activity and longer duration of inflammation, especially in Crohn’s disease 
(Pinto, 2013). Se supplementation studies suggest use as a therapeutic target 





C. Selenium and Barrier Dysfunction 
Cell-cell junction dysfunction and delocalization associated with 
inflammatory events, especially in the gut, have been widely researched (Al-
Sadi, 2007; Groschwitz, 2009; Vaziri, 2012). Tight junctions are thought to be 
the main target for therapy, since they play a major role in sealing the 
membrane to prevent leakage of harmful agents into surrounding tissues. 
Acute inflammation creates cracks in these tight seals to allow immune 
defenses to clean the area of potential threats. However, if these junctions are 
not resealed, the inflammation may not fully resolve and may develop into 
chronic inflammation and/or cancer. Multiple therapies have been studied to 
directly and indirectly restore these junctions to proper functionality: 
Berberine (Gu, 2011), Moxibustion (Bao, 2011), Carbachol (Zhang, 2014), 
and Vasoactive intestinal peptides (Conlin, 2009). Se is a dietary nutrient that 
has shown plentiful benefits in healthcare and has been considered as a 
therapeutic strategy in a colitis model as well as in a cancer model (Martin, 
2007). However, research on tight junction restoration after an inflammatory 
event with the use of Se is minimal. Studies suggest that Se may be used to 
decrease ROS, which helps to eliminate a potential threat for tight junction 
dysfunction (Keshavarzian, 2003). Furthermore, one study has observed the 
effects of a Se, gamma linolenic acid, and iodine on tight junctions in human 
breast cancer cells. This study revealed that supplementation with any of these 
alone or in combination enhanced tight junction function by relocation of ZO-
1 to the apical surface with subsequent decreased paracellular permeability 
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(Martin, 2007). There are currently few to no studies looking at Se and mucus 
production. There is one study that shows Se protects the mucosal layer by an 
unknown mechanism in rats given diaspirin cross-linked hemoglobin (DBBF-
Hb) (Baldwin, 2002). More research is needed to elucidate the role of Se in 
restoring barrier function and possible prevention of prolonged acute 
inflammation in the gut. 
D. DSS-Induced Colitis Mouse Model 
Dextran sodium sulfate (DSS) is a negatively charged sulfated polysaccharide 
that when ingested may induce damage. The DSS model of intestinal 
inflammation in mice was developed by Okayasyu and collegues (1990) and 
has been a widely used representative and reproducible model for IBD and 
acute colitis for many years (Okayasu, 1990). This model promotes epithelial 
damage by way of the toxic sulfate groups, which creates a large 
inflammatory response in the intestines, especially the colon, for several days 
after administration. The advantages to this model are that the dosages may be 
varied in order to bring about acute injury, chronic injury, or a specific time 
course of injury by dissolving DSS in drinking water. Another advantage to 
this model is that the development of disease is slow and steady, which is 
optimal for studying the different stages of disease pathogenesis. Furthermore, 
it is known that DSS-induced colitis brings about disruption and changes the 
expression of tight junction proteins as well as disrupts the mucosal layer of 
the intestines by depletion of goblet cells (Chassaing, 2014). The typical 
exposure of DSS to induce significant acute colitis is 4-7 days of low dose 
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DSS (2-3%), which brings about weight loss, immune cell infiltration, and 
barrier dysfunction. Studies looking into barrier restoration allowed mice to 
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Background: Acute Dextran Sodium Sulfate (DSS)-induced colitis is an inflammatory 
ailment limited to the colon. It works to destroy the morphology and gut barrier goblet 
and epithelial cells that aid in providing homeostasis. Selenium (Se) is an essential 
micronutrient that has anti-inflammatory and antioxidant properties and is known to play 
a role in reducing inflammation in areas elsewhere in the body. The current study is 
focused on how Se alters gut barrier permeability and functionality related to the 
recovery of tight junction regulation and mucin secretion. Methods: C57BL/6 mice were 
randomly placed into control (normal water) and 2% DSS water receiving groups and 
within these groups they were randomly given either a Se rich diet or a control diet ad 
libidum. Hemotoxylin-Eosin and Alcian Blue staining was used to study the colon 
morphology and to quantify the goblet to epithelial cell ratio. Western Blot was used to 
analyze protein expression levels for MUC-2 and ZO-1. Gut barrier permeability was 
assessed by administering FD4 and determining its plasma concentration by 
spectrofluorescence. ELISA was used to study the colon-secreted cytokine levels of TNF-
α and IL-1β. Results: DSS + Se mice showed significantly lower clinical scores, 
histopathology, higher goblet to epithelial cell ratios compared to DSS mice given a 
control diet. It is interesting to note that there was a main effect of diet and DSS treatment 
with ZO-1 expression. We found no significant difference between the groups for gut
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permeability as well as for MUC-2 expression or IL-1β and TNF-α secretion. 
Conclusion: The data suggests that Se works to reduce the severity of colitis by 
increasing ZO-1 expression and goblet cell content.  
Keywords: Selenium; Acute Colitis; Inflammation; Gut Barrier; Mucin; Tight Junction 
INTRODUCTION 
Inflammatory bowel disease (IBD) has been a growing concern in the United 
States and all over the world. IBD can be classified as either Ulcerative Colitis (UC) or 
Crohn’s Disease (CD) and has been characterized by chronic uncontrolled inflammation 
that results in damage to the lining of the gastrointestinal tract, blood in stools, diarrhea, 
and weight loss (Abraham, 2009; Matter, 2011). It is estimated that as many as 1.4 
million American’s, or 1 in every 200 people, suffer from IBD and as many as 70,000 
new cases appear each year (Hanauer, 2006). The peak onset of the disease has been 
shown to be from 15 to 30 years of age with most recent data suggesting a higher 
incidence before the age of 20 (Abraham, 2009; M’Koma 2013). Studies have shown that 
individuals suffering from IBD for at least 6-8 years are six times more likely to develop 
colorectal cancer (M’Koma 2013; Mattar, 2011).  Acute colitis is a single inflammatory 
flare-up that presents the same symptoms of IBD except on a much lower scale 
(Keshavarzian, 2003). These acute flare-ups have been attributed to genetic and non-
genetic factors. However, genetics have only been able to account for 20-25% of 
susceptibility, while environmental (diet, exercise, drugs, smoking, and social stress), 
immunological, and microbial factors play a larger role (Keshavarzian, 2003). Acute 
colonic flare-ups that are frequent and reoccurring are more indicative of chronic 
inflammation, which may lead to the development of IBD.  
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The GI tract must prevent leakage of gut bacteria into the abdominal cavity for if 
it does not, acute inflammatory immune responses may occur (Matricon, 2008; 
McGuckin, 2009). The intestines are home to trillions of commensal bacteria that make 
up a microbiome. This population of bacteria is tightly regulated and the immune system 
is highly responsive in distinguishing harmful bacteria from commensal (Johannson, 
2013). Studies examining IBD development have found concomitant intestinal barrier 
dysfunction and increased intestinal permeability allowing bacteria to leak outside of the 
intestines (Matricon, 2010). The gut barrier is made of an outer mucus layer and an inner 
single layer of epithelial cells that are held together by tight junctions (TJ) (Antoni, 
2014). TJ are composed of zona occludens (ZO) that are located at the apical surface of 
the epithelial cells. These cell junctions are the rate-limiting step in paracellular 
permeability (Clayburgh, 2004). Inflammation can downregulate their overall expression 
and translocate them to the inside of the cell away from the surface causing increased 
paracellular leakage of noxious bacteria (Ma, 2004). Inflammatory cytokines tumor 
necrosis factor alpha (TNF-α) and interleukin factor 1 beta (IL-1β have been shown to be 
able to alter intestinal TJ permeability (Ma, 2004; Wang, 2005). Furthermore, reactive 
oxygen species (ROS) may also cause oxidative stress-induced inflammation and lead to 
decreased intestinal barrier function by downregulation of TJ proteins (Keshavarzian, 
2003). TJs are the main regulatory site for paracellular permeability and are highly 
investigated in inflammatory diseases (Clayburgh, 2004). However, further research is 
needed in examining nutritional effects on TJ expression as well as how these effects may 
alter other portions of the gut barrier in acute colitis. 
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In addition to tight junction regulation, the secretive functions of gut epithelial 
cells can have a role in intestinal permeability. The mucus layer is composed of a two-
layered system that regulates the luminal bacterial environment and is important for the 
protection of the barrier epithelial cells (Johansson, 2013). The inner layer is formed by 
mucins (Muc 2, 3, and 4) that are secreted by goblet cells. In this layer there is relatively 
no bacteria, which provides the protective function to the epithelial cells. On the other 
hand, the outer layer has the same mucins as the inner layer, but here is where the 
bacteria in the gut thrive (Johansson, 2013). UC cases show diminished outer layer of 
mucus causing the bacteria and other noxious agents to move to the inside layer putting 
them in direct contact with apical epithelial surface. The diminished outer layer has been 
correlated with a loss of goblet cells and their secreted mucins (Dorofeyev, 2013). While 
mucous production is important for gut protection, further work is needed to determine 
how nutrition impacts the secretory function of gut epithelial cells. 
Selenium (Se) is an essential micronutrient that exerts its anti-inflammatory and 
antioxidant effects through many families of selenoproteins. Dietary supplementation of 
Se has been shown to play a role in thyroid hormone metabolism, cardiovascular health, 
prevention and reduction of cancer, and immune function (Huang, 2012).  A deficiency in 
Se has been negatively correlated with IBD, which suggests a crucial role of Se in 
inflammatory pathology (Barrett, 2013). Research has shown that Se can shift 
macrophage polarization from an M1 pro-inflammatory state to an M2 anti-inflammatory 
state after an insult of injury (Nelson, 2011). Additionally, glutathione peroxidases (Gpx), 
a major family of selenoproteins, have been found to decrease inflammation, reduce 
ROS, and decrease cancer incidence in mouse models of inflammation-associated 
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carcinogenesis (Krehl, 2012). Deficiency in subtypes of Gpx, Gpx-1, Gpx-2, or both, 
have shown development of spontaneous intestinal inflammation and increased apoptosis 
of intestinal epithelial cells (Edelblum, 2006; Krehl, 2012).  While Se has shown 
beneficial effects in various disease states the effects on gut barrier dysfunction, 
especially tight junction regulation and mucus production, is not very well understood.  
Se has demonstrated positive effects in reducing inflammation and preserving epithelial 
cells. In cell models of human breast cancer, Se has enhanced the function of TJs by 
relocation of ZO-1 proteins to the apical surface, thus decreasing permeability (Martin, 
2007).  Additionally, rat models examining stress and chemically induced gastric ulcers 
have found Se to prevent gastric wall mucus depletion. (al-Moutairy, 1996).  The current 
study is focused on how Se alters gut barrier functionality related to the recovery of tight 
junction regulation and mucin secretion.  However, there are currently gaps in our 
understanding or how Se can impact intestinal barrier function in a mouse model of acute 
colitis. Thus, we examined Se function with a widely used mouse model of intestinal 
inflammation, dextran sodium sulfate (DSS) - induced colitis (Perse, 2012). This model 
has demonstrated acute, chronic, and relapsing experimental inflammation and has been 
shown to closely resemble human IBD (Okayasu, 1990; Perse, 2012). 
METHODS 
Animals and Housing 
Four to five week old male and female C57BL/6 mice  (n=33) were bred and maintained 
in the animal resource facility at the University of South Carolina. They were housed 
three-five per cage and maintained on a 12:12 light-dark cycle in a low stress 
environment (22°, 50% humidity, low noise). Mice were split into two main groups: 
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control (n=15) and experimental (n=18). The control group consisted of a mixed 
population, while only males were placed in the experimental groups. Each main group 
was subdivided into mice receiving either a Control diet (0.02ppm Se) (n=17) or a Se rich 
diet (0.75ppm Se) (n=16). After 1 week of either diet, experimental mice were given 2% 
Dextran Sodium Sulfate (DSS) (MP Biochemicals, MW 36,000 – 50,000) dissolved in 
their drinking water for 5 days followed by 5 days of normal drinking water to induce 
acute colitis. Control mice were given normal drinking water ad libitum throughout the 
duration of the study. All animal experiments were approved by the University of South 
Carolina’s Institutional Animal Care and Use Committee.  
Monitoring Animal Health 
Food and water intake, as well as body weight, were measured every alternate day 
for all mice throughout the length of the study. During and following DSS treatment in 
experimental groups, mice were observed every alternate day for clinical signs of disease, 
which included weight loss, diarrhea, and positive fecal hemoccult. Weight loss was 
ranked by a point system as follows: 0= 0-5% weight loss; 1=6-10% weight loss; 2=11-
15% weight loss; 3=16-20% weight loss; and 4=>20% weight loss. The appearance of 
diarrhea was ranked as 0= well-formed pellets, 2= pasty and semi-formed stools that do 
not adhere to the anus, 4= liquid stools with no form that do not adhere to the anus. 
Positive hemoccult was scored as follows: 0= no blood or negative hemoccult, 2= some 
blood (<50%) or positive hemoccult, and 4= gross bleeding (>50%) using hemoccult kit 
(Beckman Coulter). The clinical score was then determined by adding and totaling the 





 All mice were sacrificed 17 days after initial induction of Se rich or Control diet. 
The mice were sacrificed within 2 hours by cervical dislocation and tissue collection was 
performed as a non-survival surgery. The mouse colon was excised and flushed with PBS 
(EMD Chemicals) and three 1cm sections of each were cut. The first section was stored 
at -80°C for protein expression studies. The second section was fixed in formalin (Fisher 
Scientific) and stored in 70% ethanol, which was later cut into 5-6μm thin sections for 
use in Hemotoxylin and Eosin (H&E) and Alcian Blue and Nuclear Fast Red staining. 
The last section was placed in 12-well plates containing 1ml of RPMI 1640 media that 
included 1% Penicillin-streptomycin (Mediatech, Inc) per well and was incubated for 24 
hours at 37°C and 5% CO2. The RPMI media containing tissue cytokines was 
centrifuged at 10,000g for 10 minutes at 15°C and the supernatant was collected and 
stored at -20°C until further analysis. 
Histology 
 The histopathology of the colon was observed through H&E staining. A standard 
protocol for H&E staining was used. The severity of colitis was quantified by a scale of 0 
to 4, where 0= no infiltration and inflammation; 2= moderate infiltration and 
inflammation; and 4= severe infiltration and inflammation with distorted crypts. To 
ensure reliability, the scoring was method was repeated three times on three tissue 
sections. The coefficient of variation for these measures was 1.4%. Alcian Blue and 
Neutral Fast Red staining was used to detect goblet and epithelial cells in the colon. 
Goblet cells were stained blue with Alcian Blue and epithelial cells were stained pink 
with Neutral Fast Red. They were quantified by goblet to epithelial ratio using 6 crypts 
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per colon section from each mouse for all treatment groups. The optimal number of 
crypts was determined by assessing goblet cell content in 2, 4, 6, 8, 10, 12, and 14 crypts 
per tissue section. The variance decreased from 2 to 6 crypts and did not substantially 
differ after 6 crypts with increased sampling. This measure was repeated three times on 
three tissues to ensure reliability. Furthermore, several tissue sections were recounted for 
goblet cell content and we found the coefficient of variation to be 1.4%. 
Gut Permeability 
Gut barrier integrity was assessed in all mice by permeability to FITC-dextran 
(MWav= 4000; FD4) (Sigma Aldrich). The FD4 was administered by gavage based on 
the animal’s body weight in grams and diluted with 125mg/ml of PBS to five hour fasted 
mice. Plasma was sampled before and 1 h after FD4 administration and measured for 
florescence as previously described by Yang et al., 2003.  
Enzyme-linked Immunosorbant Assay 
The RPMI medium supplemented with secreted colon cytokines was used to 
quantify the local concentrations of TNFα and IL-1β (BD biosciences) using 
commercially available  BD OptEIA enzyme-linked immunoabsorbant assay (ELISA) 
kits, according to the manufacturer’s instructions. The local cytokine concentrations were 
normalized by the estimated protein content in the colon supernatant by a Bradford 
protein assay. 
Western Blotting 
Colon tissue samples frozen at -80°C were homogenized in RIPA buffer that was 
supplemented with protease and phosphatase inhibitors (SIGMA). The samples were then 
centrifuged at 10,000 rpm for 15 minutes and the supernatant was collected for protein 
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analysis by a standard Bradford assay. Protein homogenate from all groups was 
electrophoresed on 7% SDS-PAGE gels and transferred to a nitrocellulose membrane for 
3 hours at 4°C. The membrane was blocked by 1X PBS and 0.1% Tween 20 for 1 hour 
and subsequently probed for ZO-1 (Abcam) and MUC-2 (Abcam) overnight. The bands 
were detected using chemiluminescence and normalized relative to GAPDH expression 
(Genetex). The bands were quantified by densitometry and expressed as mean area 
density by using Image J software (Image J). 
Statistical Analysis 
SAS/STAT statistical software version 9.3 was used to perform all statistical 
analysis. Two-way repeated measures analysis of variance (ANOVA) was used to 
determine significance and interactions in clinical scores between experimental groups. 
In this analysis, the repeated measure was time. Two-way ANOVA with Tukey post hoc 
analysis were used to determine significance and interactions for all other variables in 
control and experimental groups.  Pearson correlations were used to determine links 
between clinical score and goblet cell content. Statistical significance was considered at p 
< 0.05 level of confidence.  
RESULTS 
Clinical Score 
 Clinical score is a tool to to assess the severity of DSS-induced colitis. 
Experimental mice were observed and assigned a clinical score every alternate day during 
the study. Clinical scores increased from the start of DSS administration until day eight in 
mice treated with DSS alone. DSS treated mice given a high Se diet showed similar 
clinical scores as the control diet group during the first six days of DSS treatment. 
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However, we saw that Se reduced clinical score significantly in the last two days of the 
study (p < 0.01) (Figure 2.1).  To elucidate the role of Se diet in reducing clinical score in 
the last few days of the experiment, we looked at colon tissue sections to assess the 
histopathology. 
Colon Morphology 
 DSS-induced colitis is associated with increased inflammation, distorted crypts, 
and high immune cell infiltration. Colon tissues were sectioned for investigation of the 
degree of inflammation and infiltration of immune cells. Figure 2.2 shows representative 
images of colon morphology and analysis of histopathology. Control mice without DSS 
treatment showed no inflammation immune cell infiltration. Furthermore, mice 
administered only a high Se diet showed no change in inflammation and immune cell 
infiltration compared with controls. DSS treatment alone showed a significant increase in 
inflammation and immune cell infiltration over controls. However, mice treated with 
DSS and given a Se rich diet showed 60% less of a degree of inflammation and 
infiltration of immune cells as compared to their control diet counterparts (Figure 2.2B). 
In order to understand how Se attenuates colitis, we studied gut barrier integrity by 
looking at goblet cell content. 
Goblet cell content 
Mucus plays a primary role in protecting the gut barrier. It is secreted from goblet 
cells that lie within the colon crypts. Goblet cells were stained blue with Alcian Blue and 
epithelial cells were stained red with Nuclear Fast Red. The cells were quantified 
histologically at 40X, but are represented at 20X (Figure 2.3A). Mice treated with DSS 
alone showed significantly reduced goblet to epithelial cell ratios compared to controls. 
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Treatment with high Se diet alone showed no change over controls. However, mice given 
DSS and a high Se diet showed higher goblet cell content compared to controls (Figure 
2.3B). Due to these positive findings, we ran a correlation between goblet cell content 
and clinical score. We found a strong negative trend between the two outcomes (r = -
0.677) (Figure 2.4). To further elucidate Se ability to attenuate colitis we measured ZO-1, 
which is another protein associated with gut barrier integrity. 
Expression of ZO-1 
 Tight junctions adhere to the apical surface of epithelial cells and prevent passage 
of noxious agents. ZO-1 is a scaffolding protein associated with the assembly of tight 
junctions and expression is reduced in DSS-induced colitis (Poritz et al., 2007). Figure 
2.5 shows the expression of ZO-1 in control and experimental mice. There was a main 
effect of Se rich diet to increase the tight junction expression of ZO-1 regardless of DSS 
treatment. Furthermore, there was a main effect of DSS to increase the expression of ZO-
1 irrespective of diet. These findings are interesting, but may reflect the tissue sampling 
and that it was taken 5 days post DSS treatment and some repair has been initiated.   
Colon tissue-secreted inflammatory cytokines 
 Colitis is associated with increased secretion of inflammatory cytokines and 
immune cell infiltration. Previous research studies have shown Se to have an anti-
inflammatory nature through its families of selenoproteins (Huang et al., 2012). We 
measured the levels of two cytokines that can be secreted during DSS-induced colitis in 
order to establish Se effect on these cytokines within this model (Figure 2.6A-B). We 
found similar levels of cytokine expression between all groups. Further analysis revealed 
no significant main effect of either diet or DSS treatment on the secretion of cytokines.  
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Gut barrier permeability 
Another way to assess gut barrier integrity is to assess its permeability to 
fluorescent-labeled sugars. FITC (or FD4) is a sugar that is too large to pass through the 
tight junctions or epithelial membranes. Colitis has been associated with damage to the 
gut barrier and higher gut permeability. In the current study, integrity of the gut barrier 
was assessed by administering FD4 to mice 1 hour before sacrifice and measuring its 
concentration in the plasma. Gut permeability was found to be at similar concentrations 
between the groups. In this experiment, we found no main effect of DSS treatment or Se 
rich diet. Furthermore, due to high variability within each group the results could not be 
accurately interpreted (Figure 2.7).  
Mucus protein expression 
 Goblet cells are known to secrete different mucins that aid in building the mucus 
layer of the gut barrier. MUC-2 relative expression levels were studied to see if the rise in 
goblet cell content relayed higher mucus secretion. MUC-2 expression levels were found 
to be similar between the groups. In this experiment, we found no main effect of DSS 
treatment or Se rich diet. Furthermore, duet to high variability between the groups these 
results cannot be accurately interpreted (Figure 2.8).  
DISCUSSION 
Inflammation is becoming a larger part of research, as it is known to be involved 
in the pathways leading to other diseases, such as cancer. Inflammatory research in the 
gastrointestinal tract has been focused on IBD and its mechanisms of development 
(Xavier, 2007). The appearance of IBD usually occurs after several acute, unresolved 
bouts of colitis. These acute instances may be brought about by genetic factors, microbial 
 
44 
factors, or more recently investigated environmental factors (Xavier, 2007). Studies are 
broadening the scope to include environmental causes, since only 20% percent of CRC 
cases are related to genetics (Keshavarzian, 2003; Clayburgh 2004).  More specifically, 
they are delving into how inflammation stemming from diet or lifestyle effects gut barrier 
function. The gut barrier is involved in regulating the permeability of ions and solutes 
from the lumen to the blood stream. Higher permeability of the gut has been associated 
with inflammation (Clayburgh, 2004). Moreover, prolonged dysregulation of the gut 
barrier has been linked to IBD (McGuckin, 2009). Treatments let alone preventions for 
colitis-associated barrier dysfunction are minimal. Se is a well-known antioxidant that 
has been linked with decreased inflammation in mouse models of chronic inflammation 
induced colon cancer (Krehl, 2012). However, there are gaps in the literature that 
elucidate the role of Se in gut barrier function in models of acute inflammation. The 
present study aims to reveal how Se impacts the severity of DSS as well as how it may 
impact the gut barrier function in a mouse model of acute colitis.  
The experimental model used in the current study was administration of Se rich 
diet (0.75 ppm) one week before DSS treatment as a preventative to acute colitis and 
compare findings to mice given a control diet (0.02 ppm). The first aim of the current 
study was to assess the severity of colitis in mice given a Se rich diet and compare to 
control diet. The severity of colitis was assessed by assigning clinical scores to 
experimental mice after the induction of DSS. Mice given a Se rich diet revealed lower 
clinical scores during the last few days of the experiment when compared to their control 
diet counterparts (Figure 2.1). These findings indicate that DSS onslaught in the colon is 
not eradicated by Se, but that Se supplementation may help restore homeostasis faster 
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than a control diet. One possible mechanism by which Se may reduce the severity of 
colitis is by increasing activity of GPx enzyme activity.  Tham et al., 2002, saw GPx 
activity rise in mice after induction of DSS for 7 days even though this study did not 
include Se rich diets (Tham, 2002). These findings suggest that inflammation allows 
endogenous sources of GPx enzymes to aid in resolving damage and allow restoration to 
occur. The current study findings may indicate that Se rich diets are adding to the 
endogenous sources of GPx and thus aiding in a faster recovery from colitis. In order to 
see if the mice are recovering from the onslaught of DSS the morphology of the colon 
was studied. Figure 2.2 indicates that experimental mice receiving a Se rich diet showed 
less inflammation and immune cell infiltration of the colon as compared to control diet. 
Furthermore, the morphology of the colon in these mice showed an appearance quite 
similar to the control mice receiving no DSS. These findings reveal that Se may be 
helping to reduce the severity of colitis, indicated by clinical score, by improving the 
morphology of the colon to a control-like appearance. In order to fully understand the 
role of Se in restoring colon morphology we examined the gut barrier function and its 
associated structures and proteins.  
The second aim of the current study was to examine Se role in gut barrier 
function. Goblet cells are considered a large part of the gut barrier, since they provide the 
secreted mucins that protect the single layer of epithelial cells at the lumen surface 
(Johansson, 2013). Goblet and epithelial cells were quantified under a microscope to see 
if Se played a role in varying goblet cell content. Figure 2.3 shows that experimental 
mice receiving a Se rich diet had a large effect on increasing goblet cell content. 
Furthermore, colitis-induced mice receiving the Se rich diet had similar goblet cell 
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content as the control mice. Studies suggest that less secreted mucins compromise the 
thin epithelial layer and may cause colon inflammation by bacterial translocation 
(Johansson, 2013). The current findings could indicate that Se helps increase goblet cell 
content in order to provide more mucus secretion for gut barrier protection. These results 
are similar to ones seen in mice given trinitrobenzenesulfonic acid-induced colitis with 
either vitamin E and/or Se administration (Ademoglu, 2004). However, since there was 
interaction between Se diet and DSS treatment we cannot be certain of these 
interpretations. To see if change in goblet cell content induced a change in secreted 
mucus the intestinal mucus secretion protein MUC-2 was analyzed in expression studies. 
Figure 2.8 shows similar MUC-2 expression levels across all groups. These data occurred 
high variability and thus cannot be accurately interpreted. However, in our lab we have 
found that Se increases goblet cell content and MUC-2 secretion in chronic 
inflammation-induced colon cancer. (Saxena, Unpublished Data). A Pearson correlation 
was ran between clinical score and goblet cells and it shows a strong negative trend 
(Figure 2.4). These findings suggest that Se works to reduce clinical score by increasing 
goblet cell content. However, this is only representative of a trend and should be further 
investigated. 
Additionally, tight junctions are a critical part of the gut barrier function as they 
provide a tightly sealed barrier against lumen pathogens. ZO-1 is a major scaffolding 
protein of tight junctions and when expression of this protein is dysregulated permeability 
of the gut barrier tends to increase (Poritz, 2007). Figure 2.5 shows significantly higher 
expression of ZO-1 in mice given Se rich diets as compared to those on control diets. 
Furthermore, there was higher ZO-1 expression in experimental mice as compared to 
 
47 
control mice.  The latter was an unexpected finding. Martin et al found that Se may 
increase ZO-1 expression in a model of human breast cancer (Martin, 2007). However, to 
date there are no studies involving Se and ZO-1 expression in the colon. The current 
study findings may indicate that Se may be healing the gut barrier by expressing more 
ZO-1, which could be linked to less inflammation and decreased clinical score seen in 
these mice. However, further analysis is needed in order to elucidate the findings of 
increased ZO-1 expression in mice with DSS and Se rich diets. Gut barrier structures and 
associated protein expressions are good indicators of in tact gut barrier function, but 
investigation in the permeability of the gut barrier will provide more insight to its 
integrity. Gut barrier permeability was assessed to observe the integrity of the gut and 
compare these findings with gut barrier associated proteins. Figure 2.7 shows no 
significant difference between any of the groups. These findings were very unexpected 
possibly due to a miscalculation resulting in ten times more FD4 administered than 
required. Furthermore, due to high variability between the groups these results cannot be 
accurately interpreted.  
Inflammation is known to cause increased circulating and secreted cytokines. The 
current study observed specific cytokines TNF-α and IL-1β, since they have been found 
to disrupt tight junction proteins and allow higher gut permeability (Turner 2009 and 
Wang 2005). Figure 2.6 shows no significance across the groups. However, control mice 
given a control diet showed higher cytokine secretion as compared to those mice on a Se 
rich diet. Furthermore, experimental mice given Se rich diet showed higher cytokine 
secretion as compared to their control diet counterparts. Increased inflammation may 
have a dual role. Acutely, it is needed to bring about immune cells and clotting agents to 
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drive resolution (Medzhitov 2008). These data suggest that Se is working in favor of 
higher secreted cytokines to bring down clinical score and aid in the recovery of colon 
morphology. However, further investigation is needed to clarify these findings.  
There were some limitations in this study. Some of the measurements taken were 
extremely variable. In order to get smaller standard errors one must input more mice to 
each group. The timing of this study was staggered due to limitations in mice received 
per week from the breeding colony. The 33 mice obtained for this study were obtained 
over four months. Another limitation was a miscalculation in the amount of FD4 given to 
the mice, which resulted in ten times the amount administered.  
In conclusion, Se was shown to have beneficial effects on the morphology of the 
colon as well as to some extent the gut barrier proteins. These positive effects may be the 
reason we saw decreased severity of colitis seen in C57BL/6 mice given DSS-induced 
colitis. However, future experiments need to focus on gut permeability and its relation to 
inflammatory cytokines and tight junction expression in order to fully understand the 
mechanism behind Se role in gut barrier recovery in colitis.  
FUTURE DIRECTIONS 
Some future directions would be to study Se on gut barrier function in a chronic 
inflammatory setting and compare those findings to the ones presented in the current 
study. Additionally, it would be interesting to include multiple sacrifices at multiple time 
points throughout the study to see how the gut barrier is changing with Se rich diet. 
Another direction would be to further investigate the timing of Se administration. The 
present study gave Se diets as a preventative one week before DSS treatment. It would be 
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interesting to study the severity of colitis if Se diet was given as a preventative for three 
to four weeks before DSS treatment. This could possibly reveal a larger reduction in the 
























Figure 2.1. Effect of Se rich diet on clinical score.  Clinical score for DSS treated 
Control (Co + DSS) and Selenium (Se + DSS) WT mice during the last 10 days of the 
study. Weightloss, diarrhea, and fecal hemoccult were used to calculate the clinical score. 
* p < 0.01 (DSS vs DSS + Se). 
Figure 2.2 A-B. Effect of Se rich diet on the morphology of the colon. (A) 
Representative Hematoxylin and Eosin stained images (20X) of the transverse colon 
section for all treatment groups. (B) The graph shows quantitative measure of the degree 
of inflammation and infiltration of immune cells in the transverse colon for all treatment 
groups. Data are expressed as a means ± SE. # p < 0.05 (Different from all other groups).  
Figure 2.3 A-B. Effect of Se rich diet on goblet cell content. (A) Representative Alcian 
Blue and Nuclear Fast Red stained images (20X) of the transverse colon section for all 
treatment groups. (B) The graph shows quantitative measure of the ratio of goblet to 
epithelial cells. Quantification performed on colon images at (40X). Data expressed as a 
means ± SE. # p < 0.01 (Different from all other groups); * p < 0.05 (DSS + Se vs 
Control).  
Figure 2.4. Correlation between clinical score and goblet cell content. Clinical Score 
negatively correlates with higher goblet cell content measured in experimental mice. Data 
are expressed as a means ± SE. r = -0.677 
Figure 2.5 A-B. Effect of Se rich diet on tight junction protein ZO-1. (A) 
Representative western blot image of the expression levels of ZO-1 as well as a ponceau 
stain. (B) Protein expression level of ZO-1 in colon tissues from all groups of mice. Data 




Figure 2.6 A-B. Effect of Se rich diet on colon tissue-secreted cytokines. The graph 
above shows profiles of cytokines (A) TNF-α and (B) IL-1β that were secreted from 
colon tissue of mice belonging to all treatment groups. Data are expressed as a means ± 
SE. No significant difference was detected between groups. 
Figure 2.7. Effect of Se rich diet on gut permeability. Gut permeability measured by 
administration of FD4 by gavage 1 hour before sacrifice in C57BL/6 mice for all 
treatment groups. Data are expressed as means ± SE.  No significant difference was 
detected between groups. 
Figure 2.8. Effect of Se rich diet on MUC-2 expression. (A) Representative western 
blot image of the expression levels of MUC-2 as well as a ponceau stain. (B) Protein 
expression level of MUC-2 in colon tissues from all groups of mice. Data are expressed 


















































































Figure 2.3 A-B. Effect of Se rich diet on goblet cell content. 
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